EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The thrombin receptor PAR4 supports visceral adipose tissue inflammation

Sonja Kleeschulte, Vivien Fischinger, Lisa Öhlke, Johannes Bode, Markus Kamler, Dobromir Dobrev, Maria Grandoch, Anke C Fender

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03097-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Sonja Kleeschulte und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, 3T3-L1 Cells, Receptors, Thrombin, Diet, High-Fat. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ernst und Berta Grimmke Stiftung, Deutsche Forschungsgemeinschaft, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombin inhibition suppresses adiposity, WAT inflammation and metabolic dysfunction in mice. Protease-activated receptor (PAR)1 does not account for thrombin-driven obesity, so we explored the culprit role of PAR4 in this context. Male WT and PAR-4 -/- mice received a high fat diet (HFD) for 8 weeks, WT controls received standard chow. Body fat was quantified by NMR. Epididymal WAT was assessed by histology, immunohistochemistry, qPCR and lipase activity assay. 3T3-L1 preadipocytes were differentiated ± thrombin, acutely stimulated ± PAR4 activating peptide (AP) and assessed by immunoblot, qPCR and U937 monocyte adhesion. Epicardial adipose tissue (EAT) from obese and lean patients was assessed by immunoblot. PAR4 was upregulated in mouse WAT under HFD. PAR4 -/- mice developed less visceral adiposity and glucose intolerance under HFD, featuring smaller adipocytes, fewer macrophages and lower expression of adipogenic (leptin, PPARγ) and pro-inflammatory genes (CCL2, IL-1β) in WAT. HFD-modified activity and expression of lipases or perilipin were unaffected by PAR4 deletion. 3T3-L1 adipocytes differentiated with thrombin retained Ki67 expression, further upregulated IL-1β and CCL2 and were more adhesive for monocytes. In mature adipocytes, PAR4-AP increased phosphorylated ERK1/2 and AKT, upregulated Ki67, CCl2, IL-β and hyaluronan synthase 1 but not TNF-α mRNA, and augmented hyaluronidase-sensitive monocyte adhesion. Obese human EAT expressed more PAR4, CD68 and CD54 than lean EAT. PAR4 upregulated in obesity supports adipocyte hypertrophy, WAT expansion and thrombo-inflammation. The emerging PAR4 antagonists provide a therapeutic perspective in this context beyond their canonical antiplatelet action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intra-Abdominal Fat3T3-L1 CellsReceptors, ThrombinDiet, High-FatMice, Inbred C57BLInflammationAnimalsMaleHumansMiceMice, KnockoutObesityAdipocytesU937 CellsMiddle Aged

Stichwörter der Autor:innen

Adipose tissueGlucose intoleranceInflammationObesityProtease-activated receptorThrombin

Substanzen

Receptors, Thrombinprotease-activated receptor 4

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Institute for Pharmacology and Clinical Pharmacology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Institute for Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.
  • Department of Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany.
  • Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Canada.
  • Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.

Förderung

  • Ernst und Berta Grimmke Stiftung
  • Deutsche Forschungsgemeinschaft
  • European Union
  • NIH HHS
  • National Institutes of Health
  • Universitätsklinikum Essen

Zitieren

APA

Kleeschulte, S., Fischinger, V., Öhlke, L., Bode, J., Kamler, M., Dobrev, D., Grandoch, M., & Fender, A. C. (2024). The thrombin receptor PAR4 supports visceral adipose tissue inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03097-5

Vancouver

Kleeschulte S, Fischinger V, Öhlke L, Bode J, Kamler M, Dobrev D, et al. The thrombin receptor PAR4 supports visceral adipose tissue inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03097-5

BibTeX
@article{Kleeschulte2024,
  author = {Kleeschulte, Sonja and Fischinger, Vivien and Öhlke, Lisa and Bode, Johannes and Kamler, Markus and Dobrev, Dobromir and Grandoch, Maria and Fender, Anke C},
  title = {The thrombin receptor PAR4 supports visceral adipose tissue inflammation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03097-5}
}
Kostenlos starten →